Case Report: osteonecrosis of the maxilla and mandible related to trastuzumab, docetaxel and carboplatin.

We present a case of a patient with HER-2 positive breast cancer who developed extensive areas of osteonecrosis in the mandible and maxilla due to the combination of trastuzumab, carboplatin, and docetaxel. The pathogenesis is discussed based on the literature.